allodynia from glp-1 Ozempic-like drugs may cause skin pain, says weight loss doctor Understanding Allodynia: A Side Effect

Description

In Canada, the non-formulary claims for GLP-1 RAs increased by more than fourfold from 14,088 claimants in 2016 to 60,120 claimants in 2021 [6]

Pemvidutide from Altimmune is another dual GLP-1/glucagon agonist with particular promise for liver disease

Fact-checked by Dr

LegitScript tackles the sale of problematic healthcare products as well as more than 60 other high-risk categories including counterfeits, weapons, and online gambling with a multi-pronged approach that employs big data, AI-powered technology, and human expertise

Studies on semaglutide show average weight loss of 10-15% in people without diabetes when combined with lifestyle modificationa significant outcome for those struggling with menopause-driven weight gain